Literature DB >> 19763912

A critical role of surgery in the treatment for paraneoplastic pemphigus caused by localized Castleman's disease.

Yujiang Fang1, Lei Zhao, Feng Yan, Xijun Cui, Yue Xia, Alicia Duren.   

Abstract

Paraneoplastic pemphigus (PNP) is an autoimmune mucocutaneous disease associated with lymphoproliferative tumors, and sometimes with a very rare tumor, Castleman's disease (CD). PNP can present as a variety of dermatological diseases, and so far, only limited studies of PNP caused by CD have been reported, resulting in its higher possibility of misdiagnosis. Because of the variability of clinical presentation of PNP caused by CD, selection of the appropriate therapeutic approach remains unclear. To investigate the efficacy of surgery to patients with PNP caused by localized CD, the clinical, laboratory and pathological data of 5 patients with PNP caused by localized CD, 3 females and 2 males, aged 34 years (ranging from 29 to 42), with the tumor size from 6 x 4 x 4 cm(3) to 8 x 8 x 7 cm(3), located in the mediastinum (n = 3) and retroperitoneum (n = 2), were compared before and after surgery. All patients underwent surgery, and the diagnosis was confirmed by pathological examination. Surgery significantly improved mucosal lesions, cured skin lesions and decreased serum pemphigus autoantibody 6 months after surgery. Most patients were followed up for 6-48 months, and they all had no clinical or radiological recurrence and remain disease free. Therefore, surgery is an effective approach to cure patients with PNP caused by localized CD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19763912     DOI: 10.1007/s12032-009-9304-y

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  20 in total

1.  Childhood paraneoplastic pemphigus associated with Castleman's tumour.

Authors:  M A Lemon; W L Weston; J C Huff
Journal:  Br J Dermatol       Date:  1997-01       Impact factor: 9.302

2.  Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients.

Authors:  E Oksenhendler; M Duarte; J Soulier; P Cacoub; Y Welker; J Cadranel; D Cazals-Hatem; B Autran; J P Clauvel; M Raphael
Journal:  AIDS       Date:  1996-01       Impact factor: 4.177

Review 3.  Castleman's disease.

Authors:  M A Goldberg; S A Deluca
Journal:  Am Fam Physician       Date:  1989-09       Impact factor: 3.292

Review 4.  Interleukin-6.

Authors:  M Lotz
Journal:  Cancer Invest       Date:  1993       Impact factor: 2.176

5.  Paraneoplastic pemphigus is a distinct neoplasia-induced autoimmune disease.

Authors:  C Camisa; T N Helm
Journal:  Arch Dermatol       Date:  1993-07

6.  Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia.

Authors:  G J Anhalt; S C Kim; J R Stanley; N J Korman; D A Jabs; M Kory; H Izumi; H Ratrie; D Mutasim; L Ariss-Abdo
Journal:  N Engl J Med       Date:  1990-12-20       Impact factor: 91.245

7.  Angiomatous lymphoid hamartoma. Report of five cases with a review of the literature.

Authors:  K S Tung; L J McCormack
Journal:  Cancer       Date:  1967-04       Impact factor: 6.860

8.  Multicentric angiofollicular lymph node hyperplasia (Castleman's disease) followed by Kaposi's sarcoma in two homosexual males with the acquired immunodeficiency syndrome (AIDS).

Authors:  N A Lachant; N C Sun; L A Leong; R S Oseas; H E Prince
Journal:  Am J Clin Pathol       Date:  1985-01       Impact factor: 2.493

9.  Expression of interleukin-6 in Castleman's disease.

Authors:  S M Hsu; J A Waldron; S S Xie; B Barlogie
Journal:  Hum Pathol       Date:  1993-08       Impact factor: 3.466

Review 10.  Retroperitoneal Castleman's tumor and paraneoplastic pemphigus: report of a case and review of the literature.

Authors:  Charalambos Menenakos; Chris Braumann; Jens Hartmann; Christoph A Jacobi
Journal:  World J Surg Oncol       Date:  2007-04-28       Impact factor: 2.754

View more
  4 in total

1.  International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.

Authors:  Frits van Rhee; Eric Oksenhendler; Gordan Srkalovic; Peter Voorhees; Megan Lim; Angela Dispenzieri; Makoto Ide; Sophia Parente; Stephen Schey; Matthew Streetly; Raymond Wong; David Wu; Ivan Maillard; Joshua Brandstadter; Nikhil Munshi; Wilbur Bowne; Kojo S Elenitoba-Johnson; Alexander Fössa; Mary Jo Lechowicz; Shanmuganathan Chandrakasan; Sheila K Pierson; Amy Greenway; Sunita Nasta; Kazuyuki Yoshizaki; Razelle Kurzrock; Thomas S Uldrick; Corey Casper; Amy Chadburn; David C Fajgenbaum
Journal:  Blood Adv       Date:  2020-12-08

2.  Recurrent corneal melting in the paraneoplastic pemphigus associated with Castleman's disease.

Authors:  Haijun Gong; Shiyou Zhou; Yuxin Hu; Yuqin Lan; Hong Zeng; Liangchun Wang; Qingyu Liu; Mei Wang
Journal:  BMC Ophthalmol       Date:  2016-07-12       Impact factor: 2.209

Review 3.  Paraneoplastic pemphigus: a short review.

Authors:  Marta Wieczorek; Annette Czernik
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-09-23

Review 4.  Non-classical forms of pemphigus: pemphigus herpetiformis, IgA pemphigus, paraneoplastic pemphigus and IgG/IgA pemphigus.

Authors:  Adriana Maria Porro; Livia de Vasconcelos Nasser Caetano; Laura de Sena Nogueira Maehara; Milvia Maria dos Santos Enokihara
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.